Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2017-06-26 Regulatory Filings
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
DNA ImmunoBody Patent Granted in Europe
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0805J' and is dated June 26, 2017. The content announces a specific corporate event: the granting of a patent for the company's technology in Europe. This type of announcement, which is a specific piece of corporate news released via the Regulatory News Service (RNS) system of the London Stock Exchange, fits best under the general 'Regulatory Filings' category, as it is not a comprehensive report (like 10-K or IR), a management change (MANG), or a financial result (ER/IR). Although it relates to Intellectual Property (IP), the format and source (RNS) strongly suggest the general regulatory announcement category.
2017-06-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is clearly identified by the header 'RNS Number : 8506F' and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', specifically reporting changes in voting rights crossing a threshold (5%) by a shareholder ('Hygea vct plc'). This type of mandatory disclosure regarding significant changes in share ownership falls directly under the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this content type.
2017-05-22 English
Holding(s) in Company
Regulatory Filings Classification · 99% confidence The document is explicitly labeled with "RNS Number : 7114F" and contains the header "TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES". This format is characteristic of regulatory notifications filed with the London Stock Exchange's Regulatory News Service (RNS). Specifically, a TR-1 form details changes in major shareholdings (crossing ownership thresholds). This fits the definition of a regulatory filing that is not one of the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is RNS (Regulatory Filings), which serves as the general category for such announcements.
2017-05-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is explicitly labeled as 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' and carries an 'RNS Number'. It details changes in the percentage of voting rights held by Legal & General Group Plc and its subsidiaries, crossing ownership thresholds (5.13%). This structure and content perfectly match the definition of a Major Shareholding Notification, which is categorized under the code MRQ in the provided schema. Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2017-05-19 English
Results of Placing
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the closing statement "This information is provided by RNS The company news service from the London Stock Exchange". The content details a 'Placing' (fundraising) that raised £5.0 million, an 'Issue of Equity', and a 'PDMR shareholding' update. This combination of corporate finance activity (fundraising/share issuance) announced via the Regulatory News Service (RNS) strongly suggests a general regulatory announcement rather than a specific periodic report (like 10-K or IR) or a specific meeting material (like AGM-R or DEF 14A). Since it is a formal regulatory announcement that doesn't fit the more specific categories like Capital/Financing Update (CAP) or Director's Dealing (DIRS) exclusively, the most appropriate general classification for an RNS announcement is 'Regulatory Filings' (RNS), although it heavily overlaps with CAP. Given the primary mechanism of release is RNS, and it covers multiple corporate actions, RNS is the best fit as a broad regulatory disclosure.
2017-05-11 English
Proposed Placing to Raise up to £5.0 million
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement dated May 11, 2017, titled 'Proposed Placing to raise up to £5.0 million'. It details the intention to issue new Ordinary Shares (Placing Shares) to raise capital for clinical development. This activity—raising capital through the issuance of new shares—falls directly under the definition of a Capital/Financing Update (CAP). Although it is an RNS announcement, the core subject matter is financing, which is a more specific category than the general 'RNS' fallback. The document is substantial (78k characters), indicating it is the primary announcement, not just a brief notice of publication.
2017-05-11 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.